Table 2.
Age, range, years | Sex | Diagnosis | Site | Intervention arm | Therapist code |
---|---|---|---|---|---|
>65 | M | RA | 1 | CBA | 01 |
>65 | F | RA | 1 | CBA | 02 |
>65 | F | pSS | 1 | CBA | 03 |
>65 | M | RA | 1 | CBA | 04 |
50–65 | M | RA | 1 | CBA | 01 |
>65 | F | RA | 1 | CBA | 01 |
>65 | F | RA | 1 | CBA | 03 |
<50 | M | AxSpA | 1 | CBA | 04 |
50–65 | F | SLE | 1 | CBA | 03 |
50–65 | F | RA | 1 | CBA | 03 |
<50 | M | PSA | 1 | CBA | 04 |
50–65 | M | RA | 2 | CBA | 05 |
50–65 | M | PSA | 2 | CBA | 05 |
>65 | F | PSA | 2 | CBA | 05 |
>65 | M | RA | 2 | CBA | 06 |
50–65 | M | RA | 3 | CBA | 07 |
<50 | F | SLE | 3 | CBA | 08 |
50–65 | F | RA | 3 | CBA | 08 |
<50 | F | SLE | 4 | CBA | 09 |
50–65 | F | SLE | 4 | CBA | 09 |
<50 | F | pSS | 5 | CBA | 10 |
50–65 | F | PSA | 6 | CBA | 11 |
>65 | F | RA | 1 | PEP | 12 |
50–65 | F | SLE | 1 | PEP | 12 |
50–65 | F | RA | 1 | PEP | 12 |
<50 | F | SLE | 1 | PEP | 12 |
50–65 | F | SLE | 1 | PEP | 12 |
50–65 | M | AxSpA | 1 | PEP | 13 |
<50 | M | AxSpA | 1 | PEP | 12 |
<50 | F | RA | 1 | PEP | 14 |
<50 | F | RA | 1 | PEP | 15 |
>65 | M | PSA | 1 | PEP | 14 |
50–65 | F | SLE | 2 | PEP | 16 |
50–65 | F | RA | 3 | PEP | 17 |
50–65 | M | AxSpA | 3 | PEP | 17 |
>65 | F | RA | 3 | PEP | 18 |
>65 | F | SLE | 4 | PEP | 19 |
50–65 | F | PSA | 4 | PEP | 19 |
50–65 | F | pSS | 5 | PEP | 20 |
50–65 | F | pSS | 5 | PEP | 20 |
<50 | F | SLE | 5 | PEP | 20 |
>65 | F | FM | 5 | PEP | 20 |
>65 | F | RA | 6 | PEP | 21 |
AxSpA: axial spondyloarthritis; CBA: cognitive behavioural approach; F: female; M: male; PEP: personalized exercise programme; pSS: primary SS.